SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Bharat Immunologicals & Biologicals Corporation informs about limited review report

12 Nov 2018 Evaluate

In pursuance of Regulation 33(3) (C) of the LODR, Bharat Immunologicals & Biologicals Corporation has informed about the submission of Limited Review Report along with the financial results for the Quarter ended 30th September 2018.

The above information is a part of company’s filings submitted to BSE.

Bharat Immunological Share Price

17.29 0.09 (0.52%)
16-Apr-2026 14:24 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1687.80
Dr. Reddys Lab 1225.30
Cipla 1231.20
Zydus Lifesciences 938.10
Lupin 2319.50
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×